Niloofar Rahmani

Array ( [id] => 7784755 [patent_doc_number] => 20120046311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/245436 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 114635 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046311.pdf [firstpage_image] =>[orig_patent_app_number] => 13245436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720901 [patent_doc_number] => 20120010236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'QUINUCLIDINE COMPOUNDS HAVING QUATERNARY AMMONIUM GROUP, ITS PREPARATION METHOD AND USE AS BLOCKING AGENTS OF ACETYLCHOLINE' [patent_app_type] => utility [patent_app_number] => 13/239892 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2418 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010236.pdf [firstpage_image] =>[orig_patent_app_number] => 13239892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417856 [patent_doc_number] => 20120245356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'Process for the Preparation of Cycloheptapyridine CGRP Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 13/236072 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3511 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13236072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401787 [patent_doc_number] => 08691840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'N-biarylamides' [patent_app_type] => utility [patent_app_number] => 13/235743 [patent_app_country] => US [patent_app_date] => 2011-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9469 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13235743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712041 [patent_doc_number] => 20120004258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'QUINUCLIDINE CARBONATE SALTS AND MEDICINAL COMPOSITION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/232415 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15660 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13232415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10975652 [patent_doc_number] => 20140378686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'Indanyl-Substituted 4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridines, Their Use as Medicament, and Pharmaceutical Preparations Comprising Them' [patent_app_type] => utility [patent_app_number] => 14/342749 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17416 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802416 [patent_doc_number] => 08440690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Quinuclidine carbonate salts and medicinal composition thereof' [patent_app_type] => utility [patent_app_number] => 13/219109 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15661 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13219109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744546 [patent_doc_number] => 20120022098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/216200 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 203943 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022098.pdf [firstpage_image] =>[orig_patent_app_number] => 13216200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160291 [patent_doc_number] => 20120101093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS BETA-SECRETASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/214762 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32612 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101093.pdf [firstpage_image] =>[orig_patent_app_number] => 13214762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784729 [patent_doc_number] => 20120046285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'BRADYKININ RECEPTOR AGONISTS AND USES THEREOF TO TREAT OCULAR HYPERTENSION AND GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 13/211827 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23890 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046285.pdf [firstpage_image] =>[orig_patent_app_number] => 13211827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9082033 [patent_doc_number] => 20130267563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'HETEROARYLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/814812 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27765 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651926 [patent_doc_number] => 20110301195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'TRIAZOLOTHIADIAZOLE INHIBITOR OF C-MET PROTEIN KINASE' [patent_app_type] => utility [patent_app_number] => 13/206954 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10843 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301195.pdf [firstpage_image] =>[orig_patent_app_number] => 13206954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567988 [patent_doc_number] => 20110288051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'TRIAZOLOPYRIDINE 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/197273 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 37367 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288051.pdf [firstpage_image] =>[orig_patent_app_number] => 13197273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797119 [patent_doc_number] => 08435987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/197322 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28024 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13197322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807154 [patent_doc_number] => 20120058107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'PYRROLO [3,2-C] PYRIDINE-4-ONE 2-INDOLINONE PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/196391 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63987 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058107.pdf [firstpage_image] =>[orig_patent_app_number] => 13196391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8630179 [patent_doc_number] => 08362251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Pyrrolo [3,2-C] pyridine-4-one 2-indolinone protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/196386 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64065 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13196386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026757 [patent_doc_number] => 08536339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity' [patent_app_type] => utility [patent_app_number] => 13/195121 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5241 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13195121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386371 [patent_doc_number] => 08263767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity' [patent_app_type] => utility [patent_app_number] => 13/195130 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5235 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13195130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663723 [patent_doc_number] => 20110312992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Inhibitors of C-Kit and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/195825 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22320 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312992.pdf [firstpage_image] =>[orig_patent_app_number] => 13195825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8266100 [patent_doc_number] => 20120165533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'OPTICALLY ACTIVE DIAZABICYCLOOCTANE DERIVATIVES AND PROCESS FOR PREPARING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/173002 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23684 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13173002 [rel_patent_id] =>[rel_patent_doc_number] =>)